After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

Central Cee & Dave look to score the highest new entry on this week’s Official Singles Chart with CRG (an abbreviation of CAN ...

The drug in question, called firicabtagene autoleucel or firi-cel, is an autologous CD22 CAR-T cell therapy that had been ...

Jefferies downgraded Cargo Therapeutics (CRGX) to Hold from Buy with a price target of $3, down from $32. The company announced the “surprising ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

Kangkan Kalita is a reporter with The Times of India and covers issues on health, education, stories of human interest while ...

A 15-year-old Valley High School student was arrested on Thursday after they were found with a loaded gun, ammunition and two knives, the Sacramento County Sheriff's Office said.

Investing.com -- Shares of CARGO Therapeutics , Inc. (NASDAQ: CRGX) plummeted 75% following the company's decision to discontinue its Phase 2 clinical trial for firicabtagene autoleucel, citing ...

Central Cee also recently announced a massive 39-day Can’t Rush Greatness World Tour that begins April 1 in Norway and will ...

CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a mid-stage trial of its lead program, firi-cel.

CARGO Therapeutics stock has reached a new 52-week low, trading at $3.09 with a market capitalization of $607 million, as ...